Week in Review: Luye May Stage $500M Singapore IPO of Healthcare Assets

January 27, 2018

Deals and Financings

• Luye Medical may conduct a $500 million IPO of its healthcare assets on the Singapore exchange;
• ARMO BioSciences, a Bay Area immuno-oncology company, completed a $128 million IPO in the US after raising capital from China VCs;
• Tmunity of Philadelphia closed a $100 million Series A with Ping An a major investor to develop Crispr and other immuno-oncology candidates;